Patientsville.com

Do You Have a Question about Your Health?

We will help You understand Your condition and Feel better! Ask Our Health Experts!

Private, Confidential and Discreet Type your question here

 letters left

RETEPLASE Safety Reports

Total RETEPLASE reports: 297.
RETEPLASE FDA safety alerts: No.
Reported deaths: 44    Reported hospitalizations: 195.
Take RETEPLASE Side Effects Survey or Share Your RETEPLASE Story. Read More Here.

Showing 1-75 of 297 Next >

Consumer or non-health professional from POLAND reported RETEPLASE problem on July 18, 2006. Male patient, 43 years of age, weighting 167.6 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: asthenia, coronary artery restenosis, electrocardiogram repolarisation abnormality, hyperthyroidism. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, ASPIRIN, CLOPIDOGREL, SIMVASTATIN, METOPROLOL, TRIMETAZIDINE, DILTIAZEM, PROPRANOLOL. Patient was hospitalized. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from POLAND on July 20, 2006. Male patient, 73 years of age, weighting 180.8 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, bradycardia, cardiac arrest, multi-organ failure, pneumonia, pulmonary oedema, respiratory failure, respiratory tract infection fungal, septic shock. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, ASPIRIN, HEPARIN, CLOPIDOGREL, CARVEDILOL, CILAZAPRIL, AMIODARONE, FUROSEMIDE. Patient was hospitalized. Patient died on 06/15/2005.

Consumer or non-health professional from POLAND reported RETEPLASE problem on July 18, 2006. Male patient, 60 years of age, weighting 180.8 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: coronary artery disease. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, HEPARIN. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from ROMANIA on July 18, 2006. Male patient, 72 years of age, weighting 209.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: accelerated idioventricular rhythm, acute respiratory failure, alanine aminotransferase increased, anuria, aspartate aminotransferase increased, bradycardia, cardiogenic shock, electromechanical dissociation, hypertension. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, CLOPIDOGREL, ASPIRIN, HEPARIN, DOBUTAMINE. Patient died on 07/08/2006.

Consumer or non-health professional from ITALY reported RETEPLASE problem on July 18, 2006. Female patient, 50 years of age, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: coronary artery stenosis. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO. Patient was hospitalized. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from ITALY on July 17, 2006. Female patient, 64 years of age, weighting 189.6 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: myocardial ischaemia. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, HEPARIN. Patient recovered.

Consumer or non-health professional from ITALY reported RETEPLASE problem on July 18, 2006. Male patient, 57 years of age, weighting 172.0 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase mb increased, chest pain, ejection fraction abnormal, electrocardiogram st segment abnormal, haemorrhage, thrombocytopenia, troponin i increased. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, HEPARIN. Patient was hospitalized. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from ITALY on July 18, 2006. Male patient, 70 years of age, weighting 176.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: melaena. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, HEPARIN. Patient recovered.

Consumer or non-health professional from ITALY reported RETEPLASE problem on July 18, 2006. Male patient, 71 years of age, weighting 110.2 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, blood glucose increased, coronary artery bypass, ischaemia. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, HEPARIN. Patient was hospitalized. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from ROMANIA on July 21, 2006. Male patient, 72 years of age, weighting 209.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: accelerated idioventricular rhythm, alanine aminotransferase increased, anuria, aspartate aminotransferase increased, bradycardia, cardiogenic shock, central venous pressure increased, electromechanical dissociation, hypertension. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, CLOPIDOGREL, ASPIRIN, HEPARIN, DOBUTAMINE. Patient died on 07/08/2006.

Consumer or non-health professional from DENMARK reported RETEPLASE problem on July 21, 2006. Female patient, 79 years of age, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: anuria, atrial fibrillation, back pain, cardiac failure congestive, carpal tunnel syndrome, chest discomfort, chest pain, dyspnoea. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, ALBYL, CLOPIDOGREL, DIGOXIN, FUROSEMIDE, POTASSIUM CHLORIDE, ESOMEPRAZOLE MAGNESIUM, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from NETHERLANDS on July 21, 2006. Male patient, 60 years of age, weighting 220.5 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: coronary artery disease. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, ACETYLSALICYLIC ACID SRT, CLOPIDOGREL, SIMVASTATIN, METFORMIN, PERINDOPRIL ERBUMINE, ACETYLSALICYLATE CALCIUM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from ITALY reported RETEPLASE problem on July 25, 2006. Male patient, 64 years of age, weighting 160.9 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: chest pain, coronary artery disease. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, HEPARIN. Patient was hospitalized. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from ROMANIA on July 21, 2006. Male patient, 47 years of age, weighting 198.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, neutrophilia. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, CLOPIDOGREL, ACETYLSALICYLIC ACID SRT, METOPROLOL TARTRATE, ATORVASTATIN CALCIUM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from ROMANIA reported RETEPLASE problem on July 20, 2006. Male patient, 47 years of age, weighting 165.3 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, HEPARIN, CLOPIDOGREL, ACETYLSALICYLIC ACID SRT. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from ITALY on July 20, 2006. Male patient, 68 years of age, weighting 198.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: angiogram abnormal, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, coronary artery disease, coronary artery thrombosis, electrocardiogram st segment abnormal, troponin increased. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, HEPARIN. Patient recovered.

Consumer or non-health professional from FRANCE reported RETEPLASE problem on July 25, 2006. Male patient, 58 years of age, weighting 152.1 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: coronary arterial stent insertion, coronary artery disease, coronary artery stenosis. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, ASPIRIN, CLOPIDOGREL, PRAVASTATIN, ATENOLOL, OMEPRAZOLE, AMLODIPINE. Patient was hospitalized. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from BULGARIA on July 21, 2006. Male patient, 78 years of age, weighting 176.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, acute respiratory distress syndrome, alanine aminotransferase increased, arterial haemorrhage, aspartate aminotransferase increased, blood bilirubin increased, cardiac failure, coronary artery stenosis, iatrogenic injury. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, NITROGLYCERIN, DOPAMINE, HEPARIN, VASOCARDIN, ASPIRIN, FENTANYL, RANITIDINE. Patient recovered.

Consumer or non-health professional from NETHERLANDS reported RETEPLASE problem on July 21, 2006. Male patient, 42 years of age, weighting 220.5 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: atelectasis, haematocrit decreased, haemoglobin decreased, pneumonia. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, BISOPROLOL FUMARATE, ACETYLSALICYLATE, CALCIUM GLUCONATE, CLOPIDOGREL, LISINOPRIL, SIMVASTATIN. Patient was hospitalized. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from ITALY on July 20, 2006. Male patient, 68 years of age, weighting 180.8 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: coronary artery disease, heart rate decreased, thrombosis. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, HEPARIN. Patient recovered.

Consumer or non-health professional from NETHERLANDS reported RETEPLASE problem on Sept 08, 2006. Male patient, 73 years of age, weighting 176.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: coronary artery stenosis. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, TICLOPIDINE, ASPIRIN, TRIMETAZIDINE, SIMVASTATIN, PERINDOPRIL ERBUMINE, PERINDOPRIL ERBUMINE. Patient was hospitalized. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from ROMANIA on July 27, 2006. Male patient, 47 years of age, weighting 198.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, interstitial lung disease, leukocytosis, neutrophilia. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, CLOPIDOGREL, ACETYLSALICYLIC ACID SRT, METOPROLOL TARTRATE, ATORVASTATIN CALCIUM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from ROMANIA reported RETEPLASE problem on July 28, 2006. Male patient, 47 years of age, weighting 165.3 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: heart rate decreased, thrombocytopenia. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, HEPARIN, CLOPIDOGREL, ACETYLSALICYLIC ACID SRT. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from ROMANIA on July 28, 2006. Male patient, 72 years of age, weighting 209.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bradycardia, cardiogenic shock, central venous pressure increased, electromechanical dissociation, hypertension, hypotension, multi-organ failure. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, CLOPIDOGREL, ASPIRIN, HEPARIN, DOBUTAMINE. Patient died on 07/08/2006.

Consumer or non-health professional from POLAND reported RETEPLASE problem on July 28, 2006. Female patient, 84 years of age, weighting 143.3 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: angina pectoris, bradycardia, coronary artery stenosis, ejection fraction decreased, red blood cell count decreased, subcutaneous haematoma. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, ASPIRIN, CLOPIDOGREL, SPIRAPRIL, METOPROLOL TARTRATE, FLUVASTATIN. Patient was hospitalized. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from BULGARIA on July 31, 2006. Male patient, 78 years of age, weighting 176.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, acute respiratory distress syndrome, alanine aminotransferase increased, arterial haemorrhage, aspartate aminotransferase increased, blood bilirubin increased, cardiac failure, coronary artery bypass, coronary artery stenosis. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, NITROGLYCERIN, DOPAMINE, HEPARIN, VASOCARDIN, ASPIRIN, FENTANYL, RANITIDINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported RETEPLASE problem on Aug 03, 2006. Male patient, weighting 198.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 07, 2006. Male patient, 59 years of age, weighting 165.3 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: blood triglycerides increased, coronary artery disease, coronary artery occlusion, coronary artery stenosis, ejection fraction decreased, high density lipoprotein decreased. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, HEPARIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from ROMANIA reported RETEPLASE problem on Aug 11, 2006. Male patient, 47 years of age, weighting 198.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, coronary artery thrombosis, diabetes mellitus non-insulin-dependent, haemoglobin decreased, interstitial lung disease, leukocytosis, neutrophilia, pericardial effusion, thrombocytopenia. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, CLOPIDOGREL, ASPIRIN, METOPROLOL TARTRATE, ATORVASTATIN CALCIUM. Patient was hospitalized. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from NETHERLANDS on Aug 11, 2006. Male patient, 71 years of age, weighting 165.3 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: cardiac failure chronic, pneumonia, renal impairment. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, ASPIRIN, FOLIC ACID, FERROUS SULPHATE, RANITIDINE, SULFASALAZINE, ROSUVASTATIN, LACTULOSE. Patient died on 03/16/2006.

Consumer or non-health professional from BULGARIA reported RETEPLASE problem on Aug 11, 2006. Male patient, 78 years of age, weighting 176.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, acute respiratory distress syndrome, alanine aminotransferase decreased, alanine aminotransferase increased, arrhythmia, arterial haemorrhage, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, NITROGLYCERIN, DOPAMINE, HEPARIN, VASOCARDIN, ASPIRIN, FENTANYL, RANITIDINE. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from ARGENTINA on Aug 08, 2006. Male patient, 77 years of age, weighting 110.2 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, bronchitis acute, cardio-respiratory arrest, cardiogenic shock, coronary artery occlusion, dehydration, dizziness, ejection fraction decreased, haematocrit decreased. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, ASPIRIN, NITROGLYCERIN, HEPARIN, CLOPIDOGREL, DIGOXIN, FUROSEMIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from BULGARIA reported RETEPLASE problem on Aug 11, 2006. Female patient, 78 years of age, weighting 165.3 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: aortic arteriosclerosis, arteriosclerosis coronary artery, bronchitis chronic, cardiac arrest, cardiac tamponade, chronic obstructive pulmonary disease, coronary artery thrombosis, emphysema, liver disorder. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, ASPIRIN, METOCLOPRAMIDE, MORPHINE, OMEPRAZOLE, HEPARIN, GLYCRYL TRINITRATE. Patient died on 06/01/2006.

RETEPLASE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 11, 2006. Male patient, 79 years of age, weighting 147.7 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: gastric cancer, gastrointestinal haemorrhage, intracardiac thrombus, non-cardiac chest pain, ventricular fibrillation. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, ASPIRIN, ENOXAPARIN, CLOPIDOGREL, FINASTERIDE, SIMVASTATIN, OMEPRAZOLE. Patient recovered.

Consumer or non-health professional from POLAND reported RETEPLASE problem on Aug 11, 2006. Male patient, 43 years of age, weighting 167.6 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: hyperthyroidism. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, ASPIRIN, CLOPIDOGREL, SIMVASTATIN, METOPROLOL TARTRATE, TRIMETAZIDINE, DILTIAZEM, PROPRANOLOL. Patient was hospitalized. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from ITALY on Aug 11, 2006. Male patient, 59 years of age, weighting 165.3 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, blood triglycerides increased, coronary artery disease, coronary artery occlusion, coronary artery stenosis, high density lipoprotein decreased. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, HEPARIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from ROMANIA reported RETEPLASE problem on Aug 11, 2006. Male patient, 52 years of age, weighting 198.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, NITROGLYCERIN, HEPARIN, CLOPIDOGREL, METOPROLOL TARTRATE, RAMIPRIL, SIMVASTATIN. Patient recovered.

RETEPLASE problem was reported by a Health Professional from POLAND on Aug 11, 2006. Female patient, 71 years of age, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: aortic valve disease, myocardial ischaemia. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO. Patient was hospitalized. Patient recovered.

Health Professional from ROMANIA reported RETEPLASE problem on Aug 16, 2006. Male patient, 52 years of age, weighting 198.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, NITROGLYCERIN, HEPARIN, CLOPIDOGREL, METOPROLOL TARTRATE, RAMIPRIL, SIMVASTATIN. Patient recovered.

RETEPLASE problem was reported by a Health Professional from ITALY on Aug 11, 2006. Male patient, 55 years of age, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: coronary artery disease. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO. Patient recovered.

Health Professional from UNITED KINGDOM reported RETEPLASE problem on Aug 11, 2006. Male patient, 78 years of age, weighting 163.1 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: coronary artery disease. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, ASPIRIN, ATORVASTATIN CALCIUM, GLIPIZIDE, BISOPROLOL FUMARATE, ALFUZOSIN, PERINDOPRIL ERBUMINE. Patient was hospitalized. Patient recovered.

RETEPLASE problem was reported by a Health Professional from BULGARIA on Aug 15, 2006. Female patient, 76 years of age, weighting 176.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: anuria, atrial fibrillation, atrial flutter, blood potassium increased, cardiac failure congestive, cardiogenic shock, thrombocytopenia, ventricular fibrillation. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, FUROSEMIDE, DOPAMINE, AMIODARONE, RAMIPRIL, GLYCERYL TRINITRATE, ACETYLSALICYLIC ACID. Patient died on 08/09/2006.

Health Professional from ITALY reported RETEPLASE problem on Aug 15, 2006. Female patient, 59 years of age, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: angina pectoris, cold sweat, electrocardiogram st segment depression, electrocardiogram t wave inversion. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO. Patient was hospitalized. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from ROMANIA on Aug 23, 2006. Male patient, 47 years of age, weighting 198.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, coronary artery thrombosis, diabetes mellitus non-insulin-dependent, ejection fraction decreased, haemoglobin decreased, interstitial lung disease, leukocytosis, neutrophilia, pericardial effusion. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, CLOPIDOGREL, ASPIRIN, METOPROLOL, ATORVASTATIN CALCIUM, HEPARIN, PERINDOPRIL ERBUMINE, FUROSEMIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from ARGENTINA reported RETEPLASE problem on Aug 25, 2006. Male patient, 77 years of age, weighting 110.2 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood potassium increased, blood sodium decreased, cardio-respiratory arrest, cardiogenic shock, coronary artery occlusion, coronary artery stenosis, dehydration, dizziness. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, ASPIRIN, NITROGLYCERIN, HEPARIN, CLOPIDOGREL, DIGOXIN, FUROSEMIDE. Patient was hospitalized. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from DENMARK on Aug 21, 2006. Female patient, 79 years of age, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: angina pectoris, anuria, atrial fibrillation, blood pressure increased, cardiac failure congestive, carpal tunnel syndrome, chest discomfort, chest pain. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, ALBYL, CLOPIDOGREL, DIGOXIN, FUROSEMIDE, POTASSIUM CHLORIDE, ESOMEPRAZOLE MAGNESIUM, PARACETAMOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from ROMANIA reported RETEPLASE problem on Aug 23, 2006. Male patient, 52 years of age, weighting 198.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: diastolic dysfunction, ejection fraction decreased, thrombocytopenia, ventricular hypertrophy, ventricular hypokinesia. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, NITROGLYCERIN, HEPARIN, CLOPIDOGREL, METOPROLOL, RAMIPRIL, SIMVASTATIN. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from BULGARIA on Aug 25, 2006. Female patient, 76 years of age, weighting 176.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: anuria, atrial fibrillation, atrial flutter, blood creatinine increased, blood potassium increased, blood pressure decreased, cardiac failure congestive, cardiogenic shock, heart rate decreased. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, FUROSEMIDE, DOPAMINE, AMIODARONE HYDROCHLORIDE, RAMIPRIL, GLYCERYL TRINITRATE, ASPIRIN. Patient died on 08/09/2006.

Consumer or non-health professional from UNITED KINGDOM reported RETEPLASE problem on Aug 23, 2006. Male patient was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, intracardiac thrombus, transient ischaemic attack. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, ASPIRIN, RAMIPRIL, FUROSEMIDE, CLOPIDOGREL, ATORVASTATIN CALCIUM. Patient was hospitalized. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 25, 2006. Male patient, 85 years of age, weighting 141.1 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: haematemesis, haemoglobin decreased. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, ASPIRIN, CLOPIDOGREL, SIMVASTATIN, LANSOPRAZOLE. Patient recovered.

Consumer or non-health professional from ARGENTINA reported RETEPLASE problem on Aug 29, 2006. Male patient, 77 years of age, weighting 110.2 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood pressure systolic increased, cardiac arrest, cardiogenic shock, dehydration, haematocrit decreased, haemoglobin decreased, hyperkalaemia, hypocalcaemia. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, ASPIRIN, NITROGLYCERIN, HEPARIN, CLOPIDOGREL, DIGOXIN, FUROSEMIDE. Patient was hospitalized. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from BULGARIA on Sept 01, 2006. Female patient, 76 years of age, weighting 176.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, atrial flutter, blood creatinine increased, blood potassium increased, blood pressure decreased, cardiac failure congestive, cardiogenic shock, coronary artery disease, coronary artery dissection. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, FUROSEMIDE, DOPAMINE, AMIODARONE HYDROCHLORIDE, RAMIPRIL, GLYCERYL TRINITRATE, ASPIRIN. Patient died on 08/09/2006.

Consumer or non-health professional from UNITED KINGDOM reported RETEPLASE problem on Aug 29, 2006. Male patient, 88 years of age, was diagnosed with myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: blood potassium increased, c-reactive protein increased, cardiovascular disorder, renal failure. RETEPLASE dosage: unknown. During the same period patient was treated with HEPARIN, CLOPIDOGREL BISULATE, PENICILLIN V, ASPIRIN, FOLIC ACID, BEHEPAN, SINEMET. Patient died.

RETEPLASE problem was reported by a Consumer or non-health professional from ARGENTINA on Aug 31, 2006. Male patient, 74 years of age, weighting 180.8 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: catheter site haematoma, haemorrhage, hypotension. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, ASPIRIN, CLOPIDOGREL, ATENOLOL, OMEPRAZOLE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported RETEPLASE problem on Sept 08, 2006. Male patient, 52 years of age, weighting 180.8 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: aortic calcification, cardiomegaly, coronary artery stenosis, ejection fraction decreased, intracardiac thrombus. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, TICLOPIDINE, RANITIDINE, ATORVASTATIN, ASPIRIN, METOPROLOL. Patient was hospitalized. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 07, 2006. Female patient, 72 years of age, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: aortic valve disease, myocardial ischaemia. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported RETEPLASE problem on Sept 07, 2006. Male patient, 47 years of age, weighting 202.8 lb, was diagnosed with myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: coronary artery stenosis. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, ASPIRIN, CARVEDILOL, SPIRONOLACTONE, CLOPIDOGREL, ATORVASTATIN, ISOSORBIDE DINITRATE, RAMIPRIL. Patient was hospitalized. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 07, 2006. Male patient, 57 years of age, weighting 176.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: coronary artery stenosis. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from BULGARIA reported RETEPLASE problem on Sept 13, 2006. Male patient, 53 years of age, weighting 147.7 lb, was diagnosed with myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen increased, haemorrhagic stroke. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, ASPIRIN, HEPARIN, GLYCERYL TRINITRATE. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from ITALY on Sept 08, 2006. Male patient, 55 years of age, weighting 205.0 lb, was diagnosed with myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: coronary artery disease. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, HEPARIN. Patient recovered.

Consumer or non-health professional from ROMANIA reported RETEPLASE problem on Sept 07, 2006. Male patient, 72 years of age, weighting 209.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, anuria, aspartate aminotransferase increased, blood pressure decreased, bradycardia, cardiac output decreased, cardiogenic shock, central venous pressure decreased, condition aggravated. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, CLOPIDOGREL, ASPIRIN, HEPARIN, DOBUTAMINE. Patient died on 07/08/2006.

RETEPLASE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 07, 2006. Male patient, 79 years of age, weighting 147.7 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: gastric cancer, gastrointestinal haemorrhage, haemoglobin decreased, metastases to liver, non-cardiac chest pain, oesophageal oedema, ventricular fibrillation, white blood cell count increased. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, ASPIRIN, ENOXAPARIN, CLOPIDOGREL, FINASTERIDE, SIMVASTATIN, OMEPRAZOLE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported RETEPLASE problem on Sept 18, 2006. Male patient, 52 years of age, weighting 198.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: hypokinesia, thrombocytopenia, ventricular hypertrophy. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, NITROGLYCERIN, HEPARIN, CLOPIDOGREL, METOPROLOL TARTRATE, RAMIPRIL, SIMVASTATIN, FAMOTIDINE. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 18, 2006. Male patient, 57 years of age, weighting 176.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis coronary artery, coronary artery occlusion, coronary artery stenosis, coronary artery thrombosis. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, ACETYLSALICYLATE, CALCIUM GLUCONATE, METOPROLOL TARTRATE, TEMAZEPAM, SIMVASTATIN, CLEXANE, PARACETAMOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported RETEPLASE problem on Sept 18, 2006. Female patient, 65 years of age, weighting 154.3 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: coronary artery stenosis, post procedural haematoma. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, METOPROLOL TARTRATE, ASPIRIN, SIMVASTATIN, TRIMETAZIDINE, TICLOPIDINE. Patient was hospitalized. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 18, 2006. Male patient, 70 years of age, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: coronary artery restenosis, echocardiogram abnormal, myocardial ischaemia. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, ASPIRIN, CLOPIDOGREL, ACEBUTOLOL, RAMIPRIL, METFORMIN, ATORVASTATIN, METFORMIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported RETEPLASE problem on Sept 18, 2006. Male patient, 47 years of age, weighting 202.8 lb, was diagnosed with myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: coronary artery stenosis. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, ASPIRIN, CARVEDILOL, SPIRONOLACTONE, CLOPIDOGREL, ATORVASTATIN, ISOSORBIDE, RAMIPRIL. Patient was hospitalized. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 18, 2006. Male patient, 74 years of age, weighting 180.8 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, haemorrhage, hypotension, platelet count decreased. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, ASPIRIN, CLOPIDOGREL, ATENOLOL, OMEPRAZOLE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported RETEPLASE problem on Sept 08, 2006. Female patient, 65 years of age, weighting 154.3 lb, was diagnosed with myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: coronary artery stenosis. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, METOPROLOL TARTRATE, ASPIRIN, SIMVASTATIN, TRIMETAZIDINE, TICLOPIDINE. Patient was hospitalized. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 18, 2006. Male patient, 58 years of age, weighting 202.8 lb, was diagnosed with myocardial infarction, acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: angina unstable, intracardiac thrombus. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, HEPARIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported RETEPLASE problem on Sept 18, 2006. Male patient, 74 years of age, weighting 154.3 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: angina unstable, blood pressure increased, coronary artery thrombosis, haematoma, procedural complication, vascular pseudoaneurysm. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, HEPARIN. Patient was hospitalized. Patient recovered.

RETEPLASE problem was reported by a Consumer or non-health professional from POLAND on Sept 20, 2006. Male patient, 73 years of age, weighting 176.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: coronary artery stenosis, haematocrit decreased, haemoglobin decreased, red blood cell count decreased. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, TICLOPIDINE, ASPIRIN, TRIMETAZIDINE, SIMVASTATIN, PERINDOPRIL ERBUMINE, METOPROLOL TARTRATE, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.

Health Professional from POLAND reported RETEPLASE problem on Sept 20, 2006. Male patient, 52 years of age, weighting 180.8 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: aortic calcification, coronary artery stenosis, ejection fraction decreased, intracardiac thrombus. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, TICLOPIDINE, RANITIDINE, ATORVASTATIN CALCIUM, ASPIRIN, METOPROLOL TARTRATE, POTASSIUM CHLORIDE, NITROGLYCERIN. Patient was hospitalized. Patient recovered.

RETEPLASE problem was reported by a Health Professional from ITALY on Sept 20, 2006. Male patient, 72 years of age, weighting 220.5 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: coronary artery stenosis, ejection fraction decreased. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, HEPARIN, ACE INHIBITOR. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from ROMANIA reported RETEPLASE problem on Sept 26, 2006. Male patient, 52 years of age, weighting 198.4 lb, was diagnosed with acute myocardial infarction and was treated with RETEPLASE. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. RETEPLASE dosage: unknown. During the same period patient was treated with REOPRO, NITROGLYCERIN, HEPARIN, CLOPIDOGREL, METOPROLOL TARTRATE, RAMIPRIL, SIMVASTATIN, FAMOTIDINE. Patient recovered.

Showing 1-75 of 297 Next >